In response to the recent detection of H5N1, in partnership with WastewaterSCAN collaborators, Verily Principal Scientist Bradley White and team developed an assay to detect H5 in wastewater samples and further researched the detection of H5 in wastewater. Verily’s initial use of the assay focused on testing wastewater samples from select areas in Texas, the apparent epicenter of new cases, revealing the presence of H5 IAV nucleic acid in wastewater samples collected shortly before and during the reported dairy cattle cases. The findings suggest that wastewater testing can serve as a public health monitoring tool by detecting new and emerging animal pathogens with zoonotic potential, like H5. Our work is ongoing. Read more in the paper co-authored by researchers from Rollins School of Public Health at Emory University, Verily and Stanford University School of Engineering
Next week at the Milken Institute Global Conference, our Chief Medical and Science Officer Andrew Trister will discuss ways to revolutionize research and democratize clinical trials through the use of technology and a data-driven approach centered around the patient. The session is on Wednesday, May 8 at 8:30am PT.
To help public health leaders keep our communities safe, we need to consider new ways of generating data in order to understand health risks, and then leverage those data to monitor and mitigate population-level disease. Learn how we’re strengthening our commitment to public health with Verily Sightline.
We’re looking forward to being at #ISPORAnnual 2024, the conference for health economics and outcomes research (HEOR). Our Head of Strategic Affairs Joe Franklin will be speaking on May 7 at the plenary session, Missing Link for HEOR: A Path Forward for HEOR Data Integration, moderated by Nancy A. Dreyer. View details: https://bit.ly/3Wl0MLH Plus, results from the Project Baseline Health Study will be shared during two poster presentations. The first will highlight findings on remote participant engagement and the second assesses validity of remote screening for symptoms of depression.
Through a full type 2 diabetes virtual care program in Spanish, including dedicated, Spanish-speaking health coaches, language support in 250 other languages and much more, Verily Onduo strives to achieve health equity for diabetes management in minority communities.
Low hand grip strength (HGS) is associated with health conditions, but the value of this measure is unclear for diverse populations. Researchers from Verily and Duke Clinical Research Institute analyzed data from participants of the Project Baseline Health Study to better understand the association between HGS and various characteristics of health in a community-dwelling population. The results, published in Nature Portfolio's Scientific Reports, show that HGS can be a useful indicator of a variety of clinical characteristics for specific demographic groups.
It is estimated that as many as 1 million people in the U.S. live with Parkinson’s disease (PD) and nearly 90,000 new cases are diagnosed yearly.* There is no cure. In support of accelerating research for treatments and cures, we are proud to collaborate with partners using Verily’s Workbench technology to increase access to high-quality Parkinson’s disease data. Since 2018, we have worked with the Accelerating Medicines Partnership® Parkinson’s disease (AMP PD) program. Verily led the development of the AMP PD Knowledge Portal, which houses and enables the sharing of de-identified data and findings among all AMP PD partners who are working to identify the most promising biomarkers for use in clinical trials for new PD treatments. Learn more about AMP PD: https://bit.ly/3JDQpek In the last year we announced a partnership with The Michael J. Fox Foundation for Parkinson's Research. They will use Verily Viewpoint Workbench to provide a collaborative and secure data environment for programs focused on providing Parkinson’s data to researchers, including Global Parkinson’s Genetics Program (GP2) and the Aligning Science Across Parkinson’s | ASAP initiatives. Learn more: https://bit.ly/3QiyWfp hashtag#ParkinsonsAwareness hashtag#ParkinsonsDisease hashtag#ClinicalResearch hashtag#FindACure * Parkinson's Foundation
In an interview with TCTMD, Sooyoon Shin, our Digital Biomarkers Clinical Science Lead, shared the results of a Verily-led study showing the potential for walking measures captured by the Verily Study Watch to help identify patients at risk for heart failure. “While research on wearables’ role in advancing cardiometabolic health has increased exponentially in recent years, our study is unique in that it looked at subclinical heart failure and did so in a real-life setting with a diverse population, and with an eye toward patient-reported outcomes,” said Sooyoon. Read more about the study, which was recently published in the Journal of Cardiac Failure.
One of the most challenging global public health problems is the spread of mosquito-borne diseases. Watch to learn how Verily Sightline Debug is used to fight these diseases by raising and releasing “good” mosquitoes. https://bit.ly/3xRcljO
Alphabet, Verily's parent company, is listed in LinkedIn Top Companies 2024: The 50 best large workplaces to grow your career in the U.S.. Top U.S. locations: San Francisco Bay Area; New York City; Seattle Most notable skills: Mobile Application Development, Artificial Intelligence, Signal Processing Most common job titles: Software Engineer, Program Manager, Product Manager Largest job functions: Engineering, Information Technology, Program and Product Management Flex work availability: 5.1% remote How they encourage employee development: Google’s “Googler-to-Googler” peer learning and coaching platform allows employees to either coach or learn from their colleagues in different fields across the company.
